Gene · 619554
Papers2,728
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,728
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS. | J Assist Reprod Genet | 2023 | 36695944 | PubTator, text mining | PubMed |
| Targeting Pim kinases in hematological cancers: molecular and clinical review. | Mol Cancer | 2023 | 36694243 | PubTator, text mining | PubMed |
| The updated development of blood-based biomarkers for Huntington's disease. | J Neurol | 2023 | 36692635 | PubTator, text mining | PubMed |
| Comprehensive overview of microRNA function in rheumatoid arthritis. | Bone Res | 2023 | 36690624 | PubTator, text mining | PubMed |
| Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer. | Int J Mol Sci | 2023 | 36674481 | PubTator, text mining | PubMed |
| Epigenetics of Thymic Epithelial Tumors. | Cancers (Basel) | 2023 | 36672310 | PubTator, text mining | PubMed |
| MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients. | Arch Oral Biol | 2023 | 36657275 | PubTator, text mining | PubMed |
| Decrease in the expression of muscle-specific miRNAs, miR-133a and miR-1, in myoblasts with replicative senescence. | PLoS One | 2023 | 36649291 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Human Podocytes In Vitro: Effects of Differentiation and APOL1 Genotype. | Kidney Int Rep | 2023 | 36644347 | PubTator, text mining | PubMed |
| Network analysis reveals miRNA crosstalk between periodontitis and oral squamous cell carcinoma. | BMC Oral Health | 2023 | 36639776 | PubTator, text mining | PubMed |
| Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. | Funct Integr Genomics | 2023 | 36625940 | PubTator, text mining | PubMed |
| Construction of atrial fibrillation-related circRNA/lncRNA-miRNA-mRNA regulatory network and analysis of potential biomarkers. | J Clin Lab Anal | 2023 | 36604807 | PubTator, text mining | PubMed |
| Circ_0124055 promotes the progression of thyroid cancer cells through the miR-486-3p/MTA1 axis. | J Endocrinol Invest | 2023 | 36604405 | PubTator, text mining | PubMed |
| Depression, perceived stress, and distress during pregnancy and EV-associated miRNA profiles in MADRES. | J Affect Disord | 2023 | 36563790 | PubTator, text mining | PubMed |
| Exosome‑encapsulated miR‑26a attenuates aldosterone‑induced tubulointerstitial fibrosis by inhibiting the CTGF/SMAD3 signaling pathway. | Int J Mol Med | 2023 | 36524378 | PubTator, text mining | PubMed |
| Expression of Circulating MicroRNAs Associated with Obesity and their Relationships with Biochemical Parameters and Health-related Physical Fitness in Children 6 to 10 Years Old in Cali, Colombia. | Microrna | 2023 | 36475330 | PubTator, text mining | PubMed |
| Advances in studies of circulating microRNAs: origination, transportation, and distal target regulation. | J Cell Commun Signal | 2023 | 36357651 | PubTator, text mining | PubMed |
| Systemic circulating microRNA landscape in Lynch syndrome. | Int J Cancer | 2023 | 36282188 | PubTator, text mining | PubMed |
| Methylation detection of circulating tumor cell miR-486-5p/miR-34c-5p in the progression of colorectal cancer. | Clin Transl Oncol | 2023 | 36243896 | PubTator, text mining | PubMed |
| Diagnostic and prognostic value of miR-486-5p, miR-451a, miR-21-5p and monocyte to high-density lipoprotein cholesterol ratio in patients with acute myocardial infarction. | Heart Vessels | 2023 | 36214846 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/619554/papers?page=17